Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1994 1
1998 1
1999 4
2000 3
2001 6
2002 3
2003 2
2004 3
2005 4
2006 14
2007 11
2008 7
2009 5
2010 8
2011 5
2012 11
2013 8
2014 7
2015 10
2016 7
2017 3
2018 2
2019 4
2020 2
2021 6
2022 6
2023 5
2024 5

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
The Autism Spectrum Quotient: Children's Version (AQ-Child).
Auyeung B, Baron-Cohen S, Wheelwright S, Allison C. Auyeung B, et al. Among authors: wheelwright s. J Autism Dev Disord. 2008 Aug;38(7):1230-40. doi: 10.1007/s10803-007-0504-z. Epub 2007 Dec 7. J Autism Dev Disord. 2008. PMID: 18064550
The Autism-Spectrum Quotient (AQ)--adolescent version.
Baron-Cohen S, Hoekstra RA, Knickmeyer R, Wheelwright S. Baron-Cohen S, et al. Among authors: wheelwright s. J Autism Dev Disord. 2006 Apr;36(3):343-50. doi: 10.1007/s10803-006-0073-6. J Autism Dev Disord. 2006. PMID: 16552625 Free article.
The amygdala theory of autism.
Baron-Cohen S, Ring HA, Bullmore ET, Wheelwright S, Ashwin C, Williams SC. Baron-Cohen S, et al. Among authors: wheelwright s. Neurosci Biobehav Rev. 2000 May;24(3):355-64. doi: 10.1016/s0149-7634(00)00011-7. Neurosci Biobehav Rev. 2000. PMID: 10781695 Review.
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial.
Palmieri C, Linden H, Birrell SN, Wheelwright S, Lim E, Schwartzberg LS, Dwyer AR, Hickey TE, Rugo HS, Cobb P, O'Shaughnessy JA, Johnston S, Brufsky A, Tilley WD, Overmoyer B. Palmieri C, et al. Among authors: wheelwright s. Lancet Oncol. 2024 Mar;25(3):317-325. doi: 10.1016/S1470-2045(24)00004-4. Epub 2024 Feb 8. Lancet Oncol. 2024. PMID: 38342115 Free article. Clinical Trial.
134 results